Diagnostic Hybrids announces FDA (510k) clearance of its D3 FastPointTM L-DFATM Respiratory Virus Identification Kit, which allows the individual detection of influenza A, influenza B, respiratory syncytial virus (RSV), human metapneumovirus (hMPV), adenovirus and parainfluenza viruses from a patients specimen in under 30 minutes.
Read MoreComplete Genomics Inc, a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009
Read MoreThe FDA has cleared the OVA1 Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass.
Read More
Waters Corp, Hardy Diagnostics, Thermo Fisher Scientific Inc
Read More
BioCision LLC, Audit MicroControls Inc, Hoefer Inc
Read More